PNC Financial Services Group Inc. lowered its position in shares of Teladoc Health, Inc. (NYSE:TDOC – Free Report) by 47.8% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,257 shares of the health services provider’s stock after selling 2,070 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Teladoc Health were worth $49,000 as of its most recent SEC filing.
A number of other institutional investors also recently modified their holdings of the business. Vanguard Group Inc. increased its holdings in shares of Teladoc Health by 11.8% during the fourth quarter. Vanguard Group Inc. now owns 17,515,127 shares of the health services provider’s stock worth $377,451,000 after purchasing an additional 1,855,480 shares during the period. ICA Group Wealth Management LLC bought a new position in shares of Teladoc Health in the fourth quarter worth $28,000. Spouting Rock Asset Management LLC raised its stake in Teladoc Health by 13.5% in the fourth quarter. Spouting Rock Asset Management LLC now owns 39,100 shares of the health services provider’s stock valued at $843,000 after purchasing an additional 4,660 shares in the last quarter. Pale Fire Capital SE bought a new stake in Teladoc Health during the fourth quarter worth about $8,960,000. Finally, Westwood Holdings Group Inc. grew its stake in Teladoc Health by 13.1% during the fourth quarter. Westwood Holdings Group Inc. now owns 69,889 shares of the health services provider’s stock worth $1,506,000 after buying an additional 8,072 shares in the last quarter. Institutional investors own 76.82% of the company’s stock.
Analyst Ratings Changes
Several brokerages have recently commented on TDOC. TD Cowen dropped their target price on shares of Teladoc Health from $16.00 to $15.00 and set a “hold” rating for the company in a research report on Friday, April 26th. JPMorgan Chase & Co. cut their target price on Teladoc Health from $19.00 to $16.00 and set a “neutral” rating for the company in a research note on Tuesday, May 21st. Wells Fargo & Company decreased their price target on Teladoc Health from $17.00 to $15.00 and set an “equal weight” rating on the stock in a research note on Monday, April 29th. Oppenheimer lowered their price target on Teladoc Health from $26.00 to $21.00 and set an “outperform” rating for the company in a report on Friday, April 26th. Finally, Stifel Nicolaus reduced their price objective on Teladoc Health from $21.00 to $16.00 and set a “hold” rating on the stock in a research note on Friday, April 26th. Thirteen analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $18.22.
Check Out Our Latest Stock Analysis on TDOC
Insider Buying and Selling at Teladoc Health
In other news, Director Karen L. Daniel sold 9,834 shares of the business’s stock in a transaction that occurred on Thursday, May 23rd. The shares were sold at an average price of $11.90, for a total value of $117,024.60. Following the transaction, the director now owns 36,995 shares in the company, valued at approximately $440,240.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, insider Laizer Kornwasser sold 10,411 shares of the firm’s stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $12.69, for a total transaction of $132,115.59. Following the completion of the sale, the insider now owns 86,070 shares of the company’s stock, valued at $1,092,228.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Karen L. Daniel sold 9,834 shares of Teladoc Health stock in a transaction that occurred on Thursday, May 23rd. The stock was sold at an average price of $11.90, for a total value of $117,024.60. Following the completion of the sale, the director now owns 36,995 shares of the company’s stock, valued at $440,240.50. The disclosure for this sale can be found here. In the last 90 days, insiders sold 32,592 shares of company stock valued at $397,064. 0.95% of the stock is currently owned by company insiders.
Teladoc Health Price Performance
Shares of NYSE:TDOC opened at $9.21 on Monday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 3.74 and a current ratio of 3.82. Teladoc Health, Inc. has a 52 week low of $9.07 and a 52 week high of $30.41. The firm has a market cap of $1.56 billion, a PE ratio of -6.53 and a beta of 0.94. The firm’s fifty day moving average is $11.16 and its 200-day moving average is $15.31.
Teladoc Health (NYSE:TDOC – Get Free Report) last announced its earnings results on Thursday, April 25th. The health services provider reported ($0.49) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.47) by ($0.02). Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.90%. The company had revenue of $646.13 million for the quarter, compared to the consensus estimate of $637.31 million. During the same period in the prior year, the business earned ($0.37) earnings per share. The firm’s revenue for the quarter was up 2.7% on a year-over-year basis. Sell-side analysts predict that Teladoc Health, Inc. will post -1.05 earnings per share for the current year.
About Teladoc Health
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Featured Articles
Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOC – Free Report).
Receive News & Ratings for Teladoc Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Teladoc Health and related companies with MarketBeat.com’s FREE daily email newsletter.
Source: defenseworld.net
